MedTrace Logo

Clinical and Economic Impact of Herpes Zoster in Cancer Patients

NCT06207487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-08-19

No results posted yet for this study

Summary

Herpes zoster (HZ) is an important infectious complication among patients with cancer, particularly in the setting of treatment-related immunosuppression. This retrospective observational cohort study aimed to characterize the clinical profile of HZ episodes and estimate direct hospital costs associated with emergency department visits and hospitalizations in patients with active malignancy treated at a Brazilian tertiary cancer center. The study also explored associations between cancer characteristics, recent oncologic therapies, and clinical outcomes, including postherpetic neuralgia, recurrence, disease dissemination, and hospital costs. Findings are intended to support future budget impact and cost-effectiveness analyses of herpes zoster vaccination in oncology populations.

Conditions

Interventions

OTHER

Herpes Zoster episode

Clinically confirmed herpes zoster episode (initial episode or recurrence) identified through electronic medical records.

Sponsors & Collaborators

  • AC Camargo Cancer Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06207487 on ClinicalTrials.gov